Scotland’s life science innovation ecosystem is on a journey to reaching the “tipping point,” the critical mass of startups and scaleups for ecosystem success, Claudia Cavalluzzo, MI:RNA Diagnostics chief operating officer, told Medtech Insight. But while the nation hosts “incredible research and teaching talent,” it is underdelivering in early-stage entrepreneurial activity compared to other countries' economies, she said.
Scotland’s Medtech Innovation Ecosystem On The Road To ‘Tipping Point’
Unique Data Opportunity Offers Promise For Ecosystem
Scotland has a strong foundation of medtech research, but to reach the ‘tipping point’ where it has gained critical startup mass, it must overcome funding challenges and foster corporate startup partnerships.
More from Conferences
More from Market Intelligence
• By
Implementing a reflex test alongside traditional prostate cancer screening is cost-effective for high-risk groups, claims Prostate Cancer Research. Oxford BioDynamics sheds light on UK market conditions influencing the adoption of its reflex test, EpiSwitch PSE.
• By
Several counties in the US state of Georgia are maternity care “deserts.” Remote monitoring of high-risk pregnancies with maternal hypertension and diabetes could help improve the state’s high rate of maternal mortality, according to leading health service provider Philips.
• By
Medtronic’s US FDA approval for BrainSense aDBS and BrainSense EI software features of the Percept neurostimulator device has quickly followed CE marking in January.